Fig. 5.
Fig. 5. Identification of R2BP as a Pax-5. / (A) Putative binding sites of transcription factors in the RAG-2 promoter. The asterisk denotes a nucleotide identical with consensus binding sequences (c-Myb, 5′-GNCNGTT-3′; Ikaros, 5′-T/CGGGAA/T-3′; Pax-5, 5′-CTTGA/GTCAAA/TGCAGT/CGT/GG/AACG/CG/ATAGC-3′27), and the minus sign shows a nucleotide nonidentical with consensus binding sequences. (B) Competition of R2BP binding with the consensus sequence of Pax-5. EMSA was performed as in Figure 4 using nuclear extract prepared from 18.8.1 cells and the −80/−17 nt RAG-2 promoter region as a probe. The consensus binding sequence for the c-Myb, Ikaros, Pax-5, or Pax-5 binding sequence mutant (Pax-5m) was used as a competitor. Histograms indicate the relative density of the C2 complex shown on the bottom. The density of the C2 complex in the absence of the competitor is denoted as 100%. (C) The effect of anti–Pax-5 antibody on EMSA. EMSA was performed as described above in the absence or the presence of anti–Pax-5 or anti–c-Myb antibody. The asterisk denotes the band shifted with the anti–Pax-5 antibody.

Identification of R2BP as a Pax-5.

(A) Putative binding sites of transcription factors in the RAG-2 promoter. The asterisk denotes a nucleotide identical with consensus binding sequences (c-Myb, 5′-GNCNGTT-3′; Ikaros, 5′-T/CGGGAA/T-3′; Pax-5, 5′-CTTGA/GTCAAA/TGCAGT/CGT/GG/AACG/CG/ATAGC-3′27), and the minus sign shows a nucleotide nonidentical with consensus binding sequences. (B) Competition of R2BP binding with the consensus sequence of Pax-5. EMSA was performed as in Figure 4 using nuclear extract prepared from 18.8.1 cells and the −80/−17 nt RAG-2 promoter region as a probe. The consensus binding sequence for the c-Myb, Ikaros, Pax-5, or Pax-5 binding sequence mutant (Pax-5m) was used as a competitor. Histograms indicate the relative density of the C2 complex shown on the bottom. The density of the C2 complex in the absence of the competitor is denoted as 100%. (C) The effect of anti–Pax-5 antibody on EMSA. EMSA was performed as described above in the absence or the presence of anti–Pax-5 or anti–c-Myb antibody. The asterisk denotes the band shifted with the anti–Pax-5 antibody.

Close Modal

or Create an Account

Close Modal
Close Modal